Efficacy News and Research

RSS

New method of spectral analysis identifies fingerprints of chemical substances with greater accuracy

Elements and their compounds will no longer be able to hide in mixtures, even if the latter are made up of many components.

11 Feb 2015

UT Southwestern leads researchers to establish National Center for Heavy Ion Radiation Therapy

UT Southwestern Medical Center is leading a Texas consortium of researchers to establish the country's first National Center for Heavy Ion Radiation Therapy that could provide clinical care and research using heavy particles for innovative new cancer treatments.

11 Feb 2015

Study suggests that gastric bypass should be used with caution to treat extreme obesity

Based on five-year follow-up of patients in a randomized clinical trial, researchers have concluded that gastric bypass is the preferred treatment for extreme obesity. This is despite the fact that it is not as effective in reducing body weight as the so-called duodenal switch.

11 Feb 2015

Research findings could lead to new standard of care for soft tissue sarcomas

Using advanced imaging technology to more precisely target radiation beams to treat soft tissue cancers (sarcomas) in the extremities significantly reduces long term side effects without effecting survival rates, according to research results published online today in the Journal of Clinical Oncology.

11 Feb 2015

eClinicalHealth announces approval of Europe's first remote clinical study in patients with diabetes

eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, is proud to announce the Ethical Committee approval of VERKKO in Finland - Europe's first remote clinical study to include full electronic informed consent.

10 Feb 2015

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.

10 Feb 2015

FDA accepts NDA filing for Inspirion Delivery Technologies' investigational drug, MorphaBond ER

Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.

10 Feb 2015

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").

9 Feb 2015

PIDS statement on ongoing measles outbreak

The Pediatric Infectious Diseases Society, an organization of physicians, scientists, and other medical professionals dedicated to treating and preventing infectious diseases, issued a statement on Feb. 5 about the ongoing measles outbreak, urging vaccination to halt the spread of the disease and to prevent future outbreaks.

9 Feb 2015

Study highlights the need for more research on trauma and other body-mind therapies

In a Theory and Hypothesis paper titled "Somatic Experiencing: Using Interoception and Proprioception as Core Elements of Trauma Therapy," published today in Frontiers in Psychology, Dartmouth investigators Peter Payne, SEP, and Mardi Crane-Godreau, PhD, note the lack of hypothesized scientific models for the mechanisms of action responsible for outcomes in Somatic Experiencing® (SE) trauma therapy and other body-mind therapies.

9 Feb 2015

Study explores effects of medical marijuana in children and teens with ASD, ADHD

As medical marijuana becomes increasingly accepted, there is growing interest in its use for children and adolescents with developmental and behavioral problems such as autism spectrum disorders (ASD) and attention-deficit/hyperactivity disorder (ADHD), according to a review in the February Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics.

9 Feb 2015

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

9 Feb 2015

Helsinn begins elsiglutide Phase IIB trial for prevention of chemotherapy-induced diarrhea

Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID). The first patients out of a planned total of 600 patients with colorectal cancer treated with chemotherapy have been dosed in the trial.

8 Feb 2015

Electronic cigarettes and smoking cessation: an interview with Professor Peter Hajek

The electronic cigarette has been invented by Chinese pharmacist Hon Lik in 2003. The rise in electronic cigarettes (EC) popularity was initially a grass root phenomenon. EC are estimated to be at least 95% safer than cigarettes and they appeal to smokers who cannot or do not want to stop smoking, but who want to reduce the risks smoking poses to their health.

5 Feb 2015

$Study assessing efficacy of Neovasc Reducer for treatment of Refractory Angina published in NEJM$

Study assessing efficacy of Neovasc Reducer for treatment of Refractory Angina published in NEJM

Neovasc Inc. today announced that the final results from its COSIRA study assessing the efficacy and safety of the Neovasc Reducer for treatment of Refractory Angina, were published today in the New England Journal of Medicine.

5 Feb 2015

Study: 45% of RTI patients inappropriately prescribed antibiotics in outpatient settings

A new study found 45 percent of patients with respiratory tract infections (RTIs) were inappropriately prescribed antibiotics in an outpatient practice of general internal medicine and family medicine.

5 Feb 2015

Researchers develop tri-layered artificial blood vessels

By combining micro-imprinting and electro-spinning techniques, researchers at Shanghai University's Rapid Manufacturing Engineering Center have developed a vascular graft composed of three layers for the first time.

5 Feb 2015

Novel EPR oximetry technique may help clinicians directly measure oxygen in cancer, stroke patients

A novel Electron Paramagnetic Resonance (EPR) oximetry technique will help clinicians directly measure oxygen and schedule treatments at times of high oxygen levels in cancer and stroke patients to improve outcomes, The EPR team at Dartmouth's Geisel School of Medicine has found.

5 Feb 2015

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.

5 Feb 2015

Can-Fite BioPharma completes patient enrollment in CF101 Phase II/III psoriasis trial

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.

4 Feb 2015

Efficacy News and Research

New method of spectral analysis identifies fingerprints of chemical substances with greater accuracy

UT Southwestern leads researchers to establish National Center for Heavy Ion Radiation Therapy

Study suggests that gastric bypass should be used with caution to treat extreme obesity

Research findings could lead to new standard of care for soft tissue sarcomas

eClinicalHealth announces approval of Europe's first remote clinical study in patients with diabetes

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

FDA accepts NDA filing for Inspirion Delivery Technologies' investigational drug, MorphaBond ER

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

PIDS statement on ongoing measles outbreak

Study highlights the need for more research on trauma and other body-mind therapies

Study explores effects of medical marijuana in children and teens with ASD, ADHD

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Helsinn begins elsiglutide Phase IIB trial for prevention of chemotherapy-induced diarrhea

Electronic cigarettes and smoking cessation: an interview with Professor Peter Hajek

Study assessing efficacy of Neovasc Reducer for treatment of Refractory Angina published in NEJM

Study: 45% of RTI patients inappropriately prescribed antibiotics in outpatient settings

Researchers develop tri-layered artificial blood vessels

Novel EPR oximetry technique may help clinicians directly measure oxygen in cancer, stroke patients

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Can-Fite BioPharma completes patient enrollment in CF101 Phase II/III psoriasis trial

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News